Evaluation of Various Approaches to Estimate Transplacental Clearance of Vancomycin for Predicting Fetal Concentrations using a Maternal–Fetal Physiologically Based Pharmacokinetic Model

IF 3.5 3区 医学 Q2 CHEMISTRY, MULTIDISCIPLINARY Pharmaceutical Research Pub Date : 2024-04-29 DOI:10.1007/s11095-024-03705-2
Yunan Yan, Qiushi Wang, Wei Wu, Hanxi Yi, Feifan Xie
{"title":"Evaluation of Various Approaches to Estimate Transplacental Clearance of Vancomycin for Predicting Fetal Concentrations using a Maternal–Fetal Physiologically Based Pharmacokinetic Model","authors":"Yunan Yan, Qiushi Wang, Wei Wu, Hanxi Yi, Feifan Xie","doi":"10.1007/s11095-024-03705-2","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Evaluating drug transplacental clearance is vital for forecasting fetal drug exposure. <i>Ex vivo</i> human placenta perfusion experiments are the most suitable approach for this assessment. Various <i>in silico</i> methods are also proposed. This study aims to compare these prediction methods for drug transplacental clearance, focusing on the large molecular weight drug vancomycin (1449.3 g/mol), using maternal–fetal physiologically based pharmacokinetic (m-f PBPK) modeling.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p><i>Ex vivo</i> human placenta perfusion experiments, <i>in silico</i> approaches using intestinal permeability as a substitute (quantitative structure property relationship (QSPR) model and Caco-2 permeability <i>in vitro-in vivo</i> correlation model) and midazolam calibration model with Caco-2 scaling were assessed for determining the transplacental clearance (CL<sub>PD</sub>) of vancomycin. The m-f PBPK model was developed stepwise using Simcyp, incorporating the determined CL<sub>PD</sub> values as a crucial input parameter for transplacental kinetics.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>The developed PBPK model of vancomycin for non-pregnant adults demonstrated excellent predictive performance. By incorporating the CL<sub>PD</sub> parameterization derived from <i>ex vivo</i> human placenta perfusion experiments, the extrapolated m-f PBPK model consistently predicted maternal and fetal concentrations of vancomycin across diverse doses and distinct gestational ages. However, when the CL<sub>PD</sub> parameter was derived from alternative prediction methods, none of the extrapolated maternal–fetal PBPK models produced fetal predictions in line with the observed data.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Our study showcased that combination of <i>ex vivo</i> human placenta perfusion experiments and m-f PBPK model has the capability to predict fetal exposure for the large molecular weight drug vancomycin, whereas other <i>in silico</i> approaches failed to achieve the same level of accuracy.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":"40 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11095-024-03705-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Evaluating drug transplacental clearance is vital for forecasting fetal drug exposure. Ex vivo human placenta perfusion experiments are the most suitable approach for this assessment. Various in silico methods are also proposed. This study aims to compare these prediction methods for drug transplacental clearance, focusing on the large molecular weight drug vancomycin (1449.3 g/mol), using maternal–fetal physiologically based pharmacokinetic (m-f PBPK) modeling.

Methods

Ex vivo human placenta perfusion experiments, in silico approaches using intestinal permeability as a substitute (quantitative structure property relationship (QSPR) model and Caco-2 permeability in vitro-in vivo correlation model) and midazolam calibration model with Caco-2 scaling were assessed for determining the transplacental clearance (CLPD) of vancomycin. The m-f PBPK model was developed stepwise using Simcyp, incorporating the determined CLPD values as a crucial input parameter for transplacental kinetics.

Results

The developed PBPK model of vancomycin for non-pregnant adults demonstrated excellent predictive performance. By incorporating the CLPD parameterization derived from ex vivo human placenta perfusion experiments, the extrapolated m-f PBPK model consistently predicted maternal and fetal concentrations of vancomycin across diverse doses and distinct gestational ages. However, when the CLPD parameter was derived from alternative prediction methods, none of the extrapolated maternal–fetal PBPK models produced fetal predictions in line with the observed data.

Conclusion

Our study showcased that combination of ex vivo human placenta perfusion experiments and m-f PBPK model has the capability to predict fetal exposure for the large molecular weight drug vancomycin, whereas other in silico approaches failed to achieve the same level of accuracy.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估万古霉素经胎盘清除率的各种方法,利用母胎生理药代动力学模型预测胎儿浓度
背景评估药物经胎盘清除率对预测胎儿药物暴露至关重要。体内人体胎盘灌注实验是最适合的评估方法。此外,还提出了各种硅学方法。本研究以大分子量药物万古霉素(1449.3 g/mol)为研究对象,通过母胎生理药代动力学(m-f PBPK)建模,比较这些药物经胎盘清除率的预测方法。方法评估了体内人体胎盘灌注实验、以肠道渗透性为替代物的硅学方法(定量结构属性关系(QSPR)模型和 Caco-2 渗透性体外-体内相关模型)以及咪达唑仑校准模型与 Caco-2 缩放模型,以确定万古霉素的经胎盘清除率(CLPD)。使用 Simcyp 逐步建立了 m-f PBPK 模型,并将确定的 CLPD 值作为经胎盘动力学的关键输入参数。通过纳入体内外人体胎盘灌注实验得出的 CLPD 参数,推断出的 m-f PBPK 模型可一致预测不同剂量和不同胎龄的万古霉素在母体和胎儿体内的浓度。结论我们的研究表明,结合体外人体胎盘灌注实验和 m-f PBPK 模型,有能力预测胎儿对大分子量药物万古霉素的暴露量,而其他硅学方法则无法达到同样的准确度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pharmaceutical Research
Pharmaceutical Research 医学-化学综合
CiteScore
6.60
自引率
5.40%
发文量
276
审稿时长
3.4 months
期刊介绍: Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to: -(pre)formulation engineering and processing- computational biopharmaceutics- drug delivery and targeting- molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)- pharmacokinetics, pharmacodynamics and pharmacogenetics. Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.
期刊最新文献
Physiologically Based Pharmacokinetic Modeling to Assess Ritonavir-Digoxin Interactions and Recommendations for Co-Administration Regimens. Pharmacological Innovations in Space: Challenges and Future Perspectives. Regulatory Role of eIF2αK4 in Amino Acid Transporter Expression in Mouse Brain Capillary Endothelial Cells. Chemical Distribution Uniformity Assessment of "Intra-Tablet" by Hyperspectral Raman Imaging Analysis. The Current State of Biotransformation Science - Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1